Latest Starpharma (ASX:SPL) News
Page 3
Page 3 of 3
Starpharma Accelerates Partnerships and Hits Record Viraleze™ Sales in Q2 FY26
29 Jan 2026
Starpharma Secures $5.5M Genentech Deal, Advances Radiotheranostics to Clinic
14 Nov 2025
Starpharma Lands $8.5M Upfront Deal with Genentech, Eyes Clinical Milestones
28 Oct 2025
Starpharma Nets $5.5M Upfront in Genentech Oncology Deal
22 Oct 2025
Starpharma and Radiopharm Forge $89M Radiotherapy Collaboration
30 Sept 2025
Starpharma and Genentech Forge $569M Oncology Collaboration
22 Sept 2025
Starpharma and Genentech Forge $570M Cancer Therapy Partnership
22 Sept 2025
Starpharma Secures $3.7M Boost from R&D Tax Incentive for 2025
28 Aug 2025
Starpharma’s FY25 Revenue Soars 183% as Loss Narrows to $10M
26 Aug 2025
Starpharma Accelerates DEP® Asset Licensing Amid Global Expansion
31 July 2025
Starpharma Advances DEP® Pipeline and Expands Market Reach with $17.2M Cash Reserve
30 Apr 2025
Starpharma Advances FDA Pathway and Expands Middle East Market with $20M Cash Buffer
29 Jan 2025